Introduction
Clinical response of breast cancer to hormonal manipulation was ®rst reported a century ago (Beatson, 1896) . The subsequent recognition that growth stimulation occurs following the interaction of estrogen with its receptor led to the development of competitively binding anti-estrogens capable of inhibiting breast cancer growth (Jordan and Murphy, 1990) . The presence of estrogen receptor on breast tumors is therefore a favourable prognostic feature (McGuire, 1986; EBTCG, 1992) . This model of therapy, based on interference with the ligandreceptor interaction has stimulated a search for further hormone receptors in human breast tissue. More recently the possible role of additional growth factors and their cell surface receptors in development and progression of breast cancer has been studied, both as predictors of prognosis and as potential targets for therapy.
In vitro, breast cells require exogenous serum-derived factors for optimal growth. Isolation of protein fractions responsible for this activity resulted in the recognition that several families of growth factors, including epidermal growth factor (EGF), transforming growth factor a (TGFa), ®broblast growth factor (FGF), insulin and insulin-like growth factors (IGF's) were important in the growth of these cells. Likewise cell-surface receptors for these growth factors have been identi®ed on breast cells and are found with variable frequency in primary human breast tumor samples (Dickson and Lippman, 1992; Kacinski et al., 1991; Harris, 1994; Chrysagekos and Dickson, 1994) . Despite these observations, reproducible growth of primary breast cancer cells in vitro remains dicult (Ethier et al., 1993; Petersen et al., 1992; Stampfer and Yaswen, 1993) . The identi®cation of new growth factors important in growth and dierentiation of normal and/or malignant breast epithelial cells may help substantially in the analysis of these tissues.
Leukemia inhibitory factor (LIF), interleukin-6 (IL-6), oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and interleukin-11 , and the recently identi®ed cardiotrophin 1 are a family of cytokines mediating overlapping and pleiotropic actions on a variety of cell types. These actions include the stimulation of acute phase protein synthesis, inhibition of adipocyte lipoprotein lipase activity, the induction of multipotential hemopoietic progenitor cell proliferation, enhancement of megakaryocyte and platelet formation and eects on neurotransmitter phenotype (Hilton et al., 1994) . Interestingly these molecules can mediate conicting actions on dierent tissues, for example, dierentiation induction in leukemic cells and inhibition of dierentiation in embryonic stem cells.
The pleiotropy and redundancy of these growth factors can be understood, at least in part, by an analysis of their receptor structure. Recent data suggests that these growth factors share a similar three dimensional structure (long chain a-helical bundle) and utilize cellular receptors that are all members of the structurally conserved hemopoietin receptor superfamily (Bazan, 1990; Gearing et al., 1989; Miyajima et al., 1992; Robinson et al., 1994) . Their receptors all have a common receptor subunit (gp130) that is essential for biological signalling (Gearing et al., 1992; Kishimoto et al., 1992; Taga et al., 1989) . For IL-6 and IL-11 it appears that intracellular signalling is mediated via a homodimer of gp130 while LIF, OSM and CNTF utilise the heterodimer between LIF and gp130. Although signalling through these complexes is very similar, they can be distinguished in some systems (Tanigawa et al., 1993 (Tanigawa et al., , 1995 . These observations have provided a unifying concept to explain the biological redundancy of these growth-factors. The hemopoietin receptor superfamily is extensive and includes the receptors for growth hormone and prolactin, both of known importance in breast cancer (Murphy et al., 1984b; Bonneterre et al., 1987) , as well as receptors for G ± CSF, GM ± CSF, LIF, CNTF, 3, 5, 6, 7, 11 and 13. Given the overlapping functions of IL-6, IL-11, LIF, OSM and CNTF, and reports of IL-6 activity in some breast cancer cell lines (Tamm et al., 1994a,b; Chen et al., 1991) , we investigated the possible role of related receptors and their ligands in regulating the growth of breast cancer cells. In this study we have examined expression of mRNA and protein for the gp130-associated receptor molecules on breast cancer cell lines and primary malignant breast tissue. In addition we have examined the impact of the various ligands on proliferation of breast cancer cell lines.
Results

RT ± PCR analysis of receptor expression on breast cancer cell lines
Initial experiments examined the expression of various receptors on 12 breast cell lines. These receptors included the LIF receptor (LIFR), IL-6R, IL-11R, CNTFR, the common gp130 signalling molecule and receptors for IL-2, 3, 6, 7 and 11, G ± CSF, GM ± CSF, growth hormone (GH) and prolactin (PRL) (Figure 1 ). Both GHR and PRLR were expressed primarily in estrogen receptor (ER) positive cell lines with inconsistent expression in ER negative cells. GHR was also expressed in the breast cell lines derived from normal tisuse, whereas PRLR was not expressed in these cells. This pattern of expression of PRLR was consistent with previous reports for these cell lines (Murphy et al., 1984a; Bonneterre et al., 1986) .
All cell lines expressed the signalling molecule gp130 and expression of the speci®c receptor components for IL-6, LIF, IL-11 and CNTF was observed in the majority of cell lines studied. Expression of the LIFR was ubiquitous and appeared equivalent to the level of gp130 as assessed by RT ± PCR. IL-11R expression was also observed in all of the cell lines except SK-BR-3 (a line originating from an ER negative breast carcinoma). However, expression of the IL-6R in the cell lines appeared variable, consistent with the variable biological eects reported for IL-6. For example expression of the IL-6R in MCF-7, T-47D and SKBR3 cell lines is consistent with previous reports of variable eects of IL-6 in these cell lines. Equally the lack of IL-6R expression in the MDA ± MB-231 cell line correlates well with reports describing its lack of activity on these cells (Danforth and Sgagsis, 1993) .
The CNTFR was readily detected in cell lines that expressed the ER, but with no expression observed in cell lines derived from normal breast nor ER negative cell lines. The pattern of expression was thus similar to PRLR expression.
In contrast to the widespread expression of gp130 and associated receptors, expression of receptors for G ± CSF, GM ± CSF, IL-2 and IL-3 was highly variable in these breast cell lines. G ± CSFR was expressed only in the BT-483 cell line. While the b common signalling subunit shared by GM ± CSF, IL-3 and IL-5 was Figure 1 Analysis of growth factor receptor expression in breast cancer cell lines assessed by RT ± PCR. Autoradiograph of RT ± PCR products obtained from the analysis of breast cell mRNA. Samples in lanes 1 and 2 are from normal breast epithelial cell lines, lanes 3 ± 7 are from ER positive breast cancer cell lines, and lanes 8 ± 12 are from ER negative breast cancer cell lines. Lane 13 is a positive control containing RNA from bone marrow (BM) and lane 14 is a negative control in which RNA was ommitted from the PCR (7ve). Products were transferred to nylon membranes prior to being probed with a 32 P-labelled oligonucleotide corresponding to the receptor indicated on the left and bActin as a control. Lanes 1 ± 2 contain RNA samples from the following cell lines respectively, 184, 184B5, BT-483, MCF-7M, MDA ± MB-134, MDA ± MB-361, T-47D, BT-20, BT-549, MDA ± MB-231, SK ± BR-3 and HBL-100. Control samples, obtained when reverse transcriptase was ommitted from the initial cDNA synthesis of each sample, gave no signal detected in six cell lines the speci®c GM ± CSFR a and IL-3R a chains were expressed in only two cell lines. The IL-2R g common signalling subunit, shared by IL-2, 4, 7, 9 and 13, was expressed in two of the breast cell lines, while for example, the IL-7R a chain was not expressed in any cell lines (data not shown).
Because of the widespread expression pattern of the gp130 molecule and associated receptors in the majority of breast cell lines compared with the variable expression of other cytokine receptors, we elected to focus on the gp130 sub-family in this study.
Action of cytokines on growth of breast cell lines
The action of IL-6, LIF, OSM, CNTF and IL-11 was examined on four breast cancer cell lines grown in monolayer culture. Striking changes in the morphology of cells were observed. Figure 2 compares morphology of untreated cells with cells exposed to OSM. MCF-7 cells exposed to OSM appeared to draw apart from neighbouring cells, and to develop a more ®broblastic phenotype. This was associated with the appearance of decreased intercellular adhesion or cellular contraction. These changes were quite marked by day 14. Transformation to a ®broblastic phenotype was also observed in the BT-549 and MDA ± MB-231 cell lines exposed to OSM, with elongation of cells and loss of intercellular contact. In contrast, T-47D cells cultured with OSM, became more rounded in appearance. Marked alterations in cell morphology were not observed in these cell lines exposed to IL-6, LIF, CNTF or IL-11. In particular the T-47D cell line has been previously reported to show changes in cell shape and reduction in junction formation in response to IL-6 (Tamm et al., 1989) . However, such changes were not observed in the current study.
Experiments were performed to determine whether these morphological changes were associated with alterations in cell growth. We examined proliferation of four breast cancer cell lines in monolayer cultures containing either IL-6, LIF, OSM, CNTF or IL-11. In this assay we observed signi®cant inhibition of cellular proliferation by OSM in 3/4 cell lines, IL-11 in 2/4 cell lines and by IL-6 and LIF in 1/4 cell lines.
The MCF-7 cell line exhibited a biological response following treatment with this family of growth factors. Results of nine experiments examining action of IL-6, LIF and OSM and ®ve experiments examining action of CNTF and IL-11 on the MCF-7 cell line are presented in Figure 3 . In control cultures of MCF-7 cells the absolute cell number increased from 10 4 /ml to 5610 4 ± 1.1610 5 /ml during the 1 week culture period. The most dramatic eect on cell proliferation was seen after 7 days exposure to OSM, with up to 94% inhibition and a mean of 85% inhibition in nine experiments (P50.001). This action of OSM was maximal at concentrations of greater than 10 ng/ml (data not shown). Exposure to LIF for 7 days resulted in an average of 37% growth inhibition (P50.01). The eect of IL-11 and IL-6 was less marked. The mean inhibition observed in response to IL-6 was 23% (P50.01). In ®ve experiments using IL-11 a mean of 27% inhibition (P=0.02) was observed. In contrast, there was no eect on cellular proliferation in ®ve experiments in which cells were treated with CNTF.
To further address the inhibitory eect of these molecules on MCF-7 cells we also examined the clonogenic potential of cells following growth in monolayer cultures for 7 days. The frequency of clonogenic MCF-7 cells in control cultures was 20 ± 60% (n=9 experiments). With OSM, LIF and IL-6 the growth inhibitory eect observed in monolayer culture were also detected in agar cultures. Results of nine experiments ( Figure 4 ) showed signi®cant reduction of colony formation by cells which had been exposed to IL-6 (P50.01), LIF (P50.01) and OSM (P50.01). In Figure 2 Cell morphology after exposure to OSM. MCF-7 cells from control cultures (a) and appearance of cells after culture for 14 days in OSM (10 ng/ml) (b). MDA ± MB-231 cells from control cultures (c) and appearance of cells after culture for 7 days in OSM (d) Figure 3 Inhibition of MCF-7 cells after 7 days in suspension culture. 10 4 MCF-7 cells were cultured in 500 ml RPMI/10% BCS with the indicated growth factor. After 7 days viable cells were counted using a hemacytometer. Results are from nine experiments, each performed in triplicate ®ve experiments exposure to IL-11 in monolayer culture did not have a detectable eect on subsequent clonogenicity (P=0.65) As in the monolayer cultures, exposure to CNTF had no eect on clonogenic potential of these cells.
Results of treatment of the cell line BT-549 with growth factor for 10 days are presented in Figure 5 (n=6 experiments). The number of BT-549 cells in control cultures increased from 10 4 /ml to 4 ± 9610 4 /ml during the 10 day culture period. Mean growth inhibition of 60% followed treatment with OSM, with up to 80% inhibition observed (P50.01). This inhibition was also apparent at 7 days (mean 60%, P50.01, data not shown). Similarly, inhibition of up to 63% (mean 56%, P50.01) in response to IL-11 was observed at 10 days however after 7 days in culture this eect was less evident (mean 30%, P=0.17). As expected from the results shown in Figure 1 with no detectable mRNA for IL-6R and very low levels of CNTFR mRNA, there was no eect on proliferation with IL-6 or CNTF on these cells. Figure 6 depicts eight experiments using the ER negative cell line, MDA ± MB-231. Inhibition of proliferation of up to 65% (mean 54%, P50.01) was observed in cells exposed to OSM. Treatment with LIF did not result in signi®cant eects on cellular proliferation. These cells did not express CNTFR (Figure 1 ) and did not respond to CNTF. Similarly the level of IL-6R expression was barely detectable (Figure 1 ) and there was no inhibition of proliferative response with IL-6.
Analysis of receptor protein expression
The response of BT-549 and MDA ± MB-231 cells to OSM but not to LIF was unexpected given that both growth factors utilize the LIF-gp130 heterodimer. Experiments were therefore performed to document LIFR expression and binding of LIF to the surface of these cells. Binding assays were performed to monitor incorporation of the respective radio-labelled ligand. BT-549 cells were cultured in 500 ml RPMI/10% BCS with the indicated growth factor. After 10 days culture viable cells were counted using a hemacytometer. Results from six experiments, each performed in triplicate Figure 6 MDA ± MB-231 cells after 7 days in monolayer culture. 10 4 MDA ± MB-231 cells were cultured in 500 ml RPMI/10% BCS with the indicated growth factor. After 7 days viable cells were counted using a hemacytometer. Results are from eight experiments, each performed in triplicate Binding of radiolabelled LIF was comparable for all cell lines. In contrast there was approximately 10-fold reduced binding of radiolabelled OSM to HBL-100 cells compared with the other cell lines (a cell line derived from normal lactating breast). Thus the failure of BT-549 cells and MDA ± MB-231 cells to respond to LIF could not be attributed to lack of expression of LIFR mRNA (Figure 1 ) nor to lack of receptor protein expression (Table 2) .
Representative Scatchard analyses are shown in Receptor expression by RT ± PCR on primary breast cancer samples Based on these results we sought to determine whether the gp130 sub-family of receptors might also be expressed on fresh tumor samples. Although it was possible that these receptors might be expressed on normal breast cells contaminating these tissue samples, the concordance between results from primary samples and analysis of cell lines suggested that this was not the case.
Typical results for expression of the gp130 subfamily of receptors from 50 clinical samples of malignant breast tissue are shown in Figure 8 . This analysis showed a strikingly similar pattern of expression of gp130 associated receptors to that observed on breast cancer cell lines. Expression of gp130, LIF and IL-11 receptors was detected on 96%, 96% and 98% of the samples respectively. By comparison, IL-6 receptor was detected in only 80% of the samples. This was consistent with the variable expression pattern of this receptor relative to LIF and IL-11 receptors that was observed on cell lines. CNTFR expression was observed in 94% of the primary breast cancer samples. This was more frequent than CNTFR expression in the cell lines, and the correlation with ER (only 68% of samples were ER positive) was less marked. It was interesting, however, that the three samples that were CNTFR negative were also ER negative. Thus the widespread expression of members of the gp130 sub-family of 
Discussion
LIF, CNTF, OSM, IL-6 and IL-11 are related cytokines that mediate an overlapping set of pleiotropic actions on a variety of cell types including hepatocytes, megakaryocytes, osteoclasts and neuronal cells. These cytokines are ligands for receptors that utilize the transmembrane signalling protein gp130 which, at least in part, explains their functional redundancy (Gearing et al., 1992; Taga et al., 1989; Kishimoto et al., 1992) . IL-6 has been previously found to have diverse actions on breast cancer cell lines in culture, including decreased cell-cell association with increased cellular motility (Tamm et al., 1991) , conversion to fibroblastoid morphology (Kruegar et al., 1991; Tamm et al., 1989 Tamm et al., , 1994a and inhibition of cellular proliferation (Chen et al., 1991) . These observations are consistent with the ®nding of high anity IL-6 receptors on some breast cancer cell lines (Chen et al., 1991) suggesting both the presence of the unique IL-6 receptor a-chain and the signal transducer gp130.
In this study RT ± PCR analyses con®rmed that gp130 was expressed in 12/12 breast cell lines and in addition that the speci®c receptors for IL-6, LIF, IL-11 and CNTF were also expressed in the majority of the cell lines. LIFR expression was observed in 12/12 and IL-11R expression in 11/12 breast cell lines. IL-6R was somewhat more variable in its expression. Figure 8 Analysis of growth factor receptor expression in primary breast cancer tissue assessed by RT ± PCR. Autoradiograph of RT ± PCR products obtained from the analysis of fresh breast tissue mRNA. Products were transferred to nylon membranes prior to being probed with a 32 P-labelled oligonucleotide corresponding to the respective receptor (Table 1) . Lanes 1 ± 15 contain RNA samples representative of the 50 cancerous breast tissue samples obtained at biopsy. These were examined for the growth factor receptors and b-actin as indicated. Control samples, obtained when reverse transcriptase was ommitted from the initial cDNA synthesis of each sample, gave no signal. In some samples (CNTFR, ER and IL-6R) a smaller hybridising PCR product was identi®ed. These bands were attributed to alternative splicing (Koehorst et al., 1993; Horiuchi et al., 1994) This was in striking contrast to infrequent and sporadic expression of other members of the cytokine receptor superfamily such as G ± CSFR, IL-7R, GM ± CSFb (analogous to gp130 in that it is shared by GM ± CSF, IL-3 and IL-5) or IL-2Rg (shared by IL-2, 4, 7, 9 and 13). A detailed study of the ligands for many of these growth factors failed to demonstrate an action on breast cancer cells (Emerman and Eaves, 1994) . In contrast, this report describes changes in cell morphology in response to treatment with OSM. Furthermore, there was signi®cant inhibition of proliferation following exposure to OSM, LIF, IL-6 and IL-11. In particular, decreased cellular proliferation was observed following exposure to OSM in 3/4 cell lines, IL-11 in 2/4 cell lines, and by IL-6 and LIF in 1/4 cell lines. These biological responses demonstrated that cell surface expression of receptors correlated well with mRNA expression. This was con®rmed for LIF and OSM where speci®c binding of radiolabelled ligand was documented. Examination of 50 samples of primary malignant breast tissue by RT ± PCR showed a similar pattern of expression of gp130 associated receptors as was found in cell lines. This indicated that expression of these receptors in cell lines was not simply the result of cellular-immortalisation or prolonged tissue culture of the cells. Rather this observation supports the hypothesis that these receptors and their ligands are of general importance in the biology of breast malignancy. Thus based on these results, this family of cytokines acts on an even wider spectrum of cell types than previously de®ned.
OSM was ®rst described as a growth inhibitor for A375 melanoma cells, and has been reported to inhibit proliferation and alter morphology in a variety of malignant cell types (Horn et al., 1990) . A similar degree of growth inhibition in response to OSM was observed in three of the breast cancer cell lines examined in this study . Morphological changes observed in these cell lines included elongation of cells and the appearance of pseudopodia, with associated decrease in intercellular adhesion. This apparent reduction in junction-forming ability may result in disruption of paracrine growth in¯uences that may be important in these cells.
In contrast to the marked inhibition of proliferation in response to OSM, MCF-7 cells showed less inhibition in response to LIF. This result is notable, since OSM and LIF both utilize the LIFR-gp130 heterodimer for signalling, and at least in some situations elicit an identical biological response (Tanigawa et al., 1993) . The dierence between OSM and LIF in MCF-7 cells may be attributable to an OSM-speci®c receptor subunit. This is further supported by the dierence in binding of OSM versus LIF (20-fold dierence in receptor number), suggesting an OSM-binding complex that is inaccessible to LIF. Similarly, OSM inhibited MDA ± MB-231 and BT-549 cells, yet there was no biological eect with LIF. Binding data also demonstrated increased binding of OSM compared with LIF (Table 2 ). This further supports the possibility of an OSM-speci®c receptor subunit expressed on breast cancer cells.
In addition to the eects of OSM and LIF on MCF-7 cells there was evidence of inhibitory eects for IL-6 and IL-11. The inhibition observed with IL-6 was comparable to that reported by previous workers (Danforth and Sgagias, 1993) but was considerably less than noted with OSM. Although the growth suppressive eects of LIF, IL-6 and IL-11 on MCF-7 cells were modest compared to OSM, they were statistically signi®cant and reproducible.
Expression of CNTFR in the cell lines correlated with ER expression, suggesting that CNTFR may be co-regulated with the ER, or that CNTFR expression may be regulated by estrogen itself. However, CNTFR expression was detected more frequently in primary malignant tissue and with no obvious correlation to ER status. This might, however, re¯ect the presence of normal CNTFR positive cells present in these tumour samples. At the concentration used in this study (100 ng/ml) (Zhang et al., 1994) there was no biological eect of CNTF apparent in any of the assays that were examined.
It seems likely that the growth of breast cancer cells is regulated by a balance between steroidal hormones, members of the EGF, FGF and IGF families, and based on the results presented here, cytokines such as OSM, LIF, IL-6 and IL-11. The expression of receptors for this group of cytokines raises the possibility that these molecules play a role in normal and malignant breast cell biology.
Materials and methods
Breast cell lines
Twelve breast cell lines were examined. Cell lines 184 (Stampfer and Bartley, 1985) and 184B5 (Walen and Stampfer, 1989) were derived from non malignant breast epithelial cells; BT-483 (Lasfargues et al., 1978) , MCF-7M (Soule et al., 1973) , MDA ± MB-134 (Cailleau et al., 1974) , MDA ± MB-361 (Cailleau et al., 1978) and T-47D (Keydar et al., 1979) cell lines originated from estrogen receptor (ER) positive breast cancer cells; BT-20 (Lasfargues and Ozzello, 1958) , BT-549 (Lasfargues et al., 1978) , MDA ± MB-231 (Cailleau et al., 1974) , SK-BR-3 (Trempe and Fogh, 1973) cell lines originated from ER negative breast cancer cells. The HBL-100 cell line is an ER negative transformed cell line, originating from normal lactating breast (Caron de Fromentel et al., 1985) .
Tissue culture
Breast cell lines were grown in monolayer in RPMI-1640 medium containing 10% (v/v) bovine calf serum (BCS) at 378C in a fully humidi®ed atmosphere, containing 10% CO 2 in air. Cell lines were passaged by treatment with 0.05% trypsin and 0.02% EDTA.
Reverse transcriptase polymerase chain reaction
Total RNA was extracted from the cell lines and primary breast cancer tissue as previously described (Buckley et al., 1993) . First strand cDNA synthesis was performed on 1 mg of total RNA. Reverse transcription was carried out at 428C for 60 min in 20 ml of 50 mM Tris.HCl pH 8.3, 20 mM KCl, 10 mM MgCl 2 , 5 mM dithiothreitol, 1 mM of each dNTP, 20 mg/ml oligo(dT) and 12.5 units of AMV reverse transcriptase (Boehringer Mannheim). Control reactions were performed for each RNA sample under identical conditions except that reverse transcriptase was omitted from the reaction. The reverse transcription reaction mixture was diluted to 100 ml with water and 5 ml was used for each PCR reaction.
PCR reactions were carried out in 50 ml of reaction buer (Boehringer Mannheim) containing 200 mM of each dNTP, 1 mM of each primer and 2.5 units of Taq polymerase (Boehringer Mannheim). The oligonucleotides used for ampli®cation of cDNA are shown in Table 1 . After an initial denaturation of 2 min at 968C PCR was performed for 30 cycles in a Hybaid Omnigene Thermal Cycler (Integrated Sciences). Each cycle consisted of 30 s denaturation at 968C, 30 s annealing at 608C and 2 min polymerisation at 728C. 20 ml of the reaction mixture was electrophoresed on a 1% (w/v) agarose gel and DNA transferred to a nylon membrane (hybond-N + , Amersham). Southern blots were performed as described previously (Reed and Mann, 1987) . Hybridisation was carried out with end-labelled oligonucleotides internal to the respective cDNA sequences (Table 1) .
Binding studies
Receptor binding assays were performed using radioiodinated LIF ([ 125 I]LIF) and OSM ([ 125 I]OSM). The radioiodination of LIF and OSM and binding assays were essentially performed as previously described (Hilton et al., 1991; Hilton and Nicola, 1992) . Brie¯y, 50 ml aliquots containing 1610 7 cells, suspended in RPMI-1640 medium containing 10% BCS, were placed in Falcon tubes with 40 ml of the respective radioiodinated ligand at 1610 5 c.p.m. per 40 ml, with or without greater than a 40-fold excess of unlabelled ligand. Incubation was carried out at room temperature for 60 min and cells were resuspended and layered over 180 ml of BCS. Cell associated and free radioiodinated ligand were separated by centrifuation. The pellet and supernatant were subsequently counted in a g-counter. 
Biological assays
Proliferation of the cell lines was measured in monolayer culture in 24 well Costar cluster plates. Cells were plated at an initial density of 10 000 cells/ml and cultured in 500 ml RPMI-1640 supplemented with 10% (v/v) BCS and with each growth factor as indicated (LIF, 1000 U/ml; IL-6, 100 ng/ml; OSM, 10 ng/ml; CNTF, 100 ng/ml; IL-11, 100 ng/ml). These concentrations are maximally active in other systems (Nandurkar et al., 1996; Hilton et al., 1994; Zhang et al., 1994; Tanigawa et al., 1995) . After 7 or 10 days at 378C in a fully humidi®ed atmosphere containing 10% CO 2 in air, cells were trypsinised and counted using a hemocytometer and an inverted microscope. Cell viability was assessed using eosin exclusion. Results were expressed as a percentage of the corresponding untreated control value for that experiment.
Clonogenic assays
Clonogenic potential of cells following monolayer culture was assessed in a semi-solid culture medium. Cells were cultured in triplicate in 35 mm Petri dishes containing 1 ml Iscove's modi®ed Dulbelco's medium (IMDM) supplemented with 25% (v/v) BCS, 0.3% (w/v) agar with ®nal concentration of growth factor as outlined above, and with 200 cells per ml for control cultures. Cultures were maintained at 378C in a humidi®ed incubator with 5% CO 2 in air. After 14 days, colonies were enumerated using a dissecting microscope. A colony was de®ned as a clone of greater than 40 cells. All cultures were performed in triplicate.
Cytokines
Human LIF was produced using the pGEX system, essentially as described (Gearing et al., 1989) , human IL-6 was the gift of Dr R Simpson (Ludwig Institute for Cancer Research, Melbourne, Australia), human CNTF was purchased from AMRAD (Melbourne, Australia) and human OSM and IL-11 were purchased from PeproTech (Rocky Hill, NJ, USA).
Statistical analysis
Statistical analysis of data was performed using the paired and unpaired Student's t-test.
